Prostate Cancer Predictors: An Overview of Findings from Recent Study

 

A 2015 study published in the journal Prostate shows prostate cancer incidence among distant relatives on both sides of a man’s family can help predict whether he will develop the disease.  According to study author Lisa Cannon-Albright, “Family history is a substantial risk factor for prostate cancer.  But typically, a clinician will ask a patient […]

 

Learn More

 

 

September is National Prostate Cancer Awareness Month

 

National Prostate Cancer Awareness Month is observed every September in the United States by health experts and advocates, and individuals concerned with men’s prostate health.  Designating a month for the disease serves the purpose of increasing public awareness of the importance of prostate health and screenings, educating about risk factors and symptoms, and advocating for […]

 

Learn More

 

 

The National Comprehensive Cancer Network® Supports SBRT for Prostate Cancer

 

The National Comprehensive Cancer Network recently updated their patient guide that supports stereotactic body radiation therapy (SBRT) for prostate cancer.  The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and effectiveness of care for patients with cancer.   NCCN aims […]

 

Learn More

 

 

Prostate Cancer Patient Testimonial

 

 

Learn More

 

 

Wellpoint Anthem Updates Policy to Include Coverage of SBRT for Prostate Cancer

 

Wellpoint Anthem Blue Cross Blue Shield, the second largest commercial payer in the United States, recently announced that it has updated its SRS/SBRT policy to cover treatment for early stage prostate cancer. Stereotactic body radiation therapy, or SBRT, is a powerful, noninvasive treatment approach that targets radiation beams to match the size and shape of […]

 

Learn More

 

 

Men’s Health Month: A Closer Look at Prostate Cancer

 

June is Men’s Health Month. Celebrated each year to coincide with Father’s Day, this time is dedicated to raising awareness of health problems men may encounter through health education, fundraising and advocacy efforts promoting early detection and treatment of disease. Among the most prevalent men’s health issues is prostate cancer. The prostate is a walnut-shaped […]

 

Learn More

 

 

Prostate Cancer Treatment Update: 2014 NCCN Guidelines

 

The National Comprehensive Cancer Network® (NCCN) recently updated its NCCN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy (SBRT) as a treatment option for prostate cancer. SBRT for prostate cancer involves five or fewer treatment sessions, minimizing disruption to men’s normal routines and lifestyles. Read more about the NCCN and their updated […]

 

Learn More

 

 

Prostate Cancer: Early Detection Guidelines

 

According to the Prostate Cancer Foundation, prostate cancer is typically slow growing, often causing no symptoms until it reaches a more advanced stage. Once the disease begins to grow more rapidly or spreads outside the prostate, it can become a larger health problem. This aggressive type of prostate cancer can occur at any age, though […]

 

Learn More

 

 

Treatment Options for Prostate Cancer

 

According to the American Cancer Society, more than 7,000 New Jersey men will be diagnosed with prostate cancer this year. The appropriate treatment option can vary greatly depending on a number of factors including the stage, grade of the tumor, age, health and lifestyle of the patient. New Jersey CyberKnife treats prostate cancer with stereotactic […]

 

Learn More

 

 

New Jersey CyberKnife Shares Advancements in Research, Prostate Cancer Treatment

 

As New Jersey CyberKnife collaborates with the University of Pittsburgh to offer an ongoing clinical trial examining stereotactic body radiation therapy (SBRT) for prostate cancer treatment, the center’s medical director, Dr. David D’Ambrosio, is spearheading an analysis of national data on CyberKnife SBRT treatment outcomes and plans to publish his findings. “The research our physician […]

 

Learn More